Trials / Recruiting
RecruitingNCT06700460
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
A Randomized Evaluation of Clinical Outcomes Following Bilateral Implantation of EVO+ ICL Lenses or Bilateral Wavefront-Optimized LASIK (EVOlve)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Vance Thompson Vision · Academic / Other
- Sex
- All
- Age
- 21 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
Detailed description
A randomized evaluation of clinical outcomes following bilateral implantation of EVO+ Visian™ Implantable Collamer™ Lenses or bilateral Wavefront-optimized LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Laser-assisted in Situ Keratomileusis | LASIK |
| DEVICE | Implantable Collamer Lens placement | EVO ICL |
Timeline
- Start date
- 2024-11-27
- Primary completion
- 2025-02-28
- Completion
- 2025-04-01
- First posted
- 2024-11-22
- Last updated
- 2025-01-09
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06700460. Inclusion in this directory is not an endorsement.